This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 9, 2021
Delivered DigitallyUS Eastern Daylight Time

Antapodia Therapeutics, Inc.

Profile

Antapodia Therapeutics is a science-driven and developmental-stage biopharmaceutical company providing breakthrough solutions for treating aggressive human cancers. The company leverages next-generation nanocarrier and gene-therapy technologies to develops first-in-class invadopodia-targeted siRNA and antibody therapies. These novel therapeutics have shown dramatic therapeutic efficacy in different types of cancers and are expected to have a high opportunity of clinical success.